Cited by 1,209Phytoestrogen effects and researchPhytochemicals and Antioxidant ActivitiesEstrogen and related hormone effects

The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones

Open access
Setchell, Kenneth D.R., Brown, Nadine M., Lydeking-Olsen, Eva·2002·The Journal of Nutrition

Abstract

Equol [7-hydroxy-3-(4'-hydroxyphenyl)-chroman] is a nonsteroidal estrogen of the isoflavone class. It is exclusively a product of intestinal bacterial metabolism of dietary isoflavones and it possesses estrogenic activity, having affinity for both estrogen receptors, ERalpha and ERbeta. Equol is superior to all other isoflavones in its antioxidant activity. It is the end product of the biotransformation of the phytoestrogen daidzein, one of the two main isoflavones found in abundance in soybeans and most soy foods. Once formed, it is relatively stable; however, equol is not produced in all healthy adults in response to dietary challenge with soy or daidzein. Several recent dietary intervention studies examining the health effects of soy isoflavones allude to the potential importance of equol by establishing that maximal clinical responses to soy protein diets are observed in people who are good "equol-producers." It is now apparent that there are two distinct subpopulations of people and that "bacterio-typing" individuals for their ability to make equol may hold the clue to the effectiveness of soy protein diets in the treatment or prevention of hormone-dependent conditions. In reviewing the history of equol, its biological properties, factors influencing its formation and clinical data, we propose a new paradigm. The clinical effectiveness of soy protein in cardiovascular, bone and menopausal health may be a function of the ability to biotransform soy isoflavones to the more potent estrogenic isoflavone, equol. The failure to distinguish those subjects who are "equol-producers" from "nonequol producers" in previous clinical studies could plausibly explain the variance in reported data on the health benefits of soy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jn/132.12.3577

Cites

121 of 121 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Daidzin and genistin, glycoside isoflavones, are converted to daidzein and genistein by bacterial beta-glucosidases, with the important estrogen equol being the end product following further biotransformation of daidzein.

    “Daidzin and genistin, glycoside isoflavones, are converted to daidzein and genistein by bacterial b-glucosidases, with the important estrogen equol being the end product following further biotransformation of daidzein (Setchell et al., 2002).”

    From Gut reactions: Breaking down xenobiotic–microbiome interactions (2019) · cites this paper as Setchell et al., 2002

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. 2002) Soy consumption and chronic disease. In: 4th International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, J. Nutr. 132: 545-619.
  2. Cassidy, A. (1991) Plant Oestrogens and Their Relation to Hormonal Status in Women. Doctoral thesis, University of Cambridge, Cambridge, UK.

Cited by

Sorted by citations

Authors
Setchell, K. D. R., Brown, N. M., & Lydeking-Olsen, E.
Affiliations
Cincinnati Children's Hospital Medical Center (US)
Corresponding author
Setchell, Kenneth D.R.
Venue
The Journal of Nutrition
Publisher
Elsevier BV
Published
2002-12
Volume
132
Issue
12
Pages
3577-3584
ISSN
0022-3166 (ISSN-L)
OpenAlex
W2114379216
Cited by
1,209
References
121
Citations by year
2026: 29 · 2025: 30 · 2024: 30 · 2023: 31 · 2022: 37 · 2021: 41 · 2020: 38 · 2019: 42 · 2018: 43 · 2017: 35 · 2016: 50 · 2015: 39 · 2014: 66 · 2013: 66 · 2012: 73
FWCI
7.18
Type
journal article
Language
en
Open access
Locations
  • Journal of Nutrition (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01ca073328-03, 5r01ca056303-03, RR08084)
  • National Cancer Institute (R01CA73328, R01CA56303)
  • National Center for Research Resources (M01RR008084, RR08084)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Phytoestrogen effects and research
  • Health Sciences › Medicine › Biochemistry › Phytochemicals and Antioxidant Activities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
Keywords
equol, soy isoflavones, daidzein, gut microbiota, phytoestrogens, estrogen receptor alpha, estrogen receptor beta, antioxidant activity, soy protein, equol producers, menopausal health, bone health, cardiovascular health, hormone-dependent diseases
MeSH terms
Adult, Animals, Chromans, Estrogens, Non-Steroidal, Humans, Isoflavones, Glycine max, Equol

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review